ORIC Pharmaceuticals, Inc. · NASDAQ:ORIC
EcoR1 Capital, LLC reported a 6.90% stake in ORIC Pharmaceuticals, Inc. (Schedule 13G)
Event Jul 29, 2025 · Filed Aug 5, 2025
EcoR1 Capital, LLC reported a 6.90% stake in ORIC Pharmaceuticals, Inc., 6,728,116 shares, as a passive investor on Jul 29, 2025. Filed Aug 5, 2025 (Schedule 13G).
- Stake
- 6.90%
- Shares
- 6,728,116
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 6.90% | 6,728,116 |
| Oleg Nodelman | 6.90% | 6,728,116 |
| EcoR1 Capital Fund Qualified, L.P. | 6.50% | 6,283,426 |
Source
Related
- ORIC Pharmaceuticals, Inc.
- EcoR1 Capital, LLC
- ORIC Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · EcoR1 Capital, LLC · Nov 16, 2026
- Schedule 13G/A · Viking Global Investors LP · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 16, 2026
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026